Armando Gabrielli

Title: Armando Gabrielli: Innovator in Medical Diagnostics

Introduction

Armando Gabrielli is a notable inventor based in Ancona, Italy. He has made significant contributions to the field of medical diagnostics, particularly in relation to the human PDGF receptor. His work has implications for the diagnosis and treatment of systemic sclerosis (SSc).

Latest Patents

Armando Gabrielli holds a patent titled "Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof." This invention refers to peptides located in the extracellular region of the human PDGF receptor (hPDGFR) alpha. The patent outlines their use for detecting auto-antibodies against hPDGFR alpha and describes a method for diagnosing or monitoring therapy for SSc. Additionally, it includes antibodies or their recombinant or synthetic derivatives that can recognize and bind to the aforementioned peptide, which can be utilized in the treatment of SSc. He has 1 patent to his name.

Career Highlights

Throughout his career, Armando has worked on innovative solutions that bridge the gap between research and practical applications in medicine. His focus on the PDGF receptor has positioned him as a key figure in advancing diagnostic methods for autoimmune diseases.

Collaborations

Armando has collaborated with notable individuals in his field, including Gianluca Moroncini and Ada Funaro. These partnerships have enhanced his research and contributed to the development of his patented technologies.

Conclusion

Armando Gabrielli's contributions to medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work continues to influence the field and offers promising avenues for future research and treatment options.